by Admin | Feb 9, 2022 | News & Opinions
By Andrew Briskin – Link to Article In a collaboration between ViaCyte and CRISPR Therapeutics, a new clinical trial is investigating a cell therapy that may eventually help millions with type 1 diabetes. Researchers have long sought a cell-based “cure” for type...
by Admin | Feb 8, 2022 | News & Opinions
Genetically modified cancer-fighting cells are now developed on campus as part of a new cellular therapy program (SACRAMENTO) Alan Gaines did two tours in the Vietnam War as a Navy fighter pilot—so being brave isn’t new to him. At 77, he was diagnosed with an...
by Admin | Jan 22, 2022 | News & Opinions
HOUSTON – (link to article) – A huge advancement in treating heart disease could be on the horizon. Researchers at the Texas Heart Institute are studying a high-tech way to use stem cells to spare lives and protect patients from the #1 killer. Your heart...
by Admin | Jan 21, 2022 | News & Opinions
By Dr. Tomislav Meštrović, MD, Ph.D. – Dec 13 2021 – News-Medical.net (link to article) A recent review in the journal Life provided a detailed description of CRISPR-Cas-based diagnostic techniques to identify severe acute respiratory syndrome coronavirus...
by Admin | Jan 20, 2022 | News & Opinions
January 20, 2022 – Washington, D.C. (link to article) – A new national poll of registered voters in the United States shows that the majority of respondents would utilize pharmaceutical intervention to target aspects of aging if the drugs or therapies were safe,...
by admin | Jan 20, 2022 | News & Opinions
NIAID Scientists Developed Vaccine Platform Image Caption: Scanning electromicrograph of an HIV-infected H9 T cell. Credit: NIAID December 9, 2021 – (Link to article) – An experimental HIV vaccine based on mRNA—the same platform technology used in two...
